Unlike traditional weight loss medications, Tirzepatide is a dual GIP and GLP-1 receptor agonist , meaning it targets two powerful hormonal pathways that control appetite, digestion, and blood sugar
ABSTRACT OBJECTIVE: Semaglutide, a novel glucagon-like peptide-1 receptor agonist, has transformed the therapeutic landscape for type 2 diabetes mellitus
This leads to a calorie deficit and increased energy expenditure, crucial for effective weight loss and the reduction of visceral adipose tissue, the harmful fat around the abdomen
Many topical products can fit daily routines, but overuse does not lead to faster results
Choosing between the two depends on your specific health goals, but both offer immense value in helping you achieve a healthier, more vital self